about
The effect of environmental chemicals on the tumor microenvironmentMatrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosisMitochondria in the spotlight of aging and idiopathic pulmonary fibrosisNicotine stimulates collagen type I expression in lung via α7 nicotinic acetylcholine receptors.Aging mesenchymal stem cells fail to protect because of impaired migration and antiinflammatory response.Pathogenesis of idiopathic pulmonary fibrosisTGFβ1 mediates alcohol-induced Nrf2 suppression in lung fibroblasts.Type V collagen induced tolerance suppresses collagen deposition, TGF-β and associated transcripts in pulmonary fibrosisBlue journal conference. Aging and susceptibility to lung disease.Plasminogen activator inhibitor 1, fibroblast apoptosis resistance, and aging-related susceptibility to lung fibrosisDecreased Laminin Expression by Human Lung Epithelial Cells and Fibroblasts Cultured in Acellular Lung Scaffolds from Aged Mice.Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalanceConformational coupling of integrin and Thy-1 regulates Fyn priming and fibroblast mechanotransductionAlteration of Aging-Dependent MicroRNAs in Idiopathic Pulmonary Fibrosis.TGF-β1 epigenetically modifies Thy-1 expression in primary lung fibroblastsSenescent Cells Contribute to the Physiological Remodeling of Aged LungsMechanisms of Lung Fibrosis Resolution.Detecting splicing variants in idiopathic pulmonary fibrosis from non-differentially expressed genes.Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis.Differential Regulation of the Extracellular Cysteine/Cystine Redox State (EhCySS) by Lung Fibroblasts from Young and Old Mice.Animal models of fibrotic lung disease.Aging promotes pro-fibrotic matrix production and increases fibrocyte recruitment during acute lung injury.Experimental basis and new insights for cell therapy in Chronic Obstructive Pulmonary Disease.Influence of age on wound healing and fibrosis.The potential of cell-based therapy in lung diseases.Translational models of lung disease.Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo.Aging and Lung Disease. Clinical Impact and Cellular and Molecular Pathways.An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis.Lung carcinogenesis and fibrosis taken together: just coincidence?Sirtuin 3 Deregulation Promotes Pulmonary Fibrosis.Exploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis."Scar-cinoma": viewing the fibrotic lung mesenchymal cell in the context of cancer biology.What Should Be Chronic: The Animal, the Model, or Both?Deregulation of selective autophagy during aging and pulmonary fibrosis: the role of TGFβ1.Mechanisms and Consequences of Oxidative Stress in Lung Disease: Therapeutic Implications for an Aging Populace.MiR-21-Mediated Suppression of Smad7 Induces TGFβ1 and Can Be Inhibited by Activation of Nrf2 in Alcohol-Treated Lung Fibroblasts.Age-related lung tissue remodeling due to the local distribution of MMP-2, TIMP-2, TGF-β and Hsp70.Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis.Club cell protein 16 (Cc16) deficiency increases inflamm-aging in the lungs of mice
P2860
Q28085138-DFECC4E4-2B91-45A6-9A58-7781DCC94E9EQ28386047-B5434BED-630A-46F3-839B-0E86A98FCB19Q29248145-ED325164-9D6C-494A-A357-CBAD7743927BQ33759288-2AF6CDA9-FDB6-4688-8B63-226364166D3CQ33770974-069843EC-3D65-4FE5-85DC-B9A8DFBAB6EDQ33976506-A64B6846-6399-4EEA-A9E6-BA5F4B46C63CQ34574163-86A82E3A-CE19-4D89-8C21-D674EDA599E5Q35034689-CC88B4C4-1A8E-4EDF-838E-6D5E6CD44D07Q35153456-3EB445D3-C178-4145-8C6F-53A6DB1B6D6FQ35261037-BFD96197-AF22-4034-A774-77A4F4B60418Q35949234-D6CB01F7-76C9-4BFA-AB70-B5369EB6F5B5Q35983620-2BFF2314-FCA9-485C-A4D3-8FA9B6008DDCQ36149399-B6D45EAE-581F-40EC-BE76-3C3359A4B0D3Q36190899-FED6BBA7-BF08-4700-9F4E-B5542043C47BQ36237065-87E88691-DCB4-4F33-8EE4-7ADA32C99FD2Q36885316-086B5355-5445-4D1F-B830-6CC09BF2F4B2Q36885732-BB208147-3774-4E46-9F55-A5EFE995CED0Q36976480-27097485-AC1F-4BEC-8348-95DA3AE58013Q37042139-74FCD6CA-26A6-4D58-95F2-8F77F5920158Q37239707-07633E01-7563-4DBE-BB58-0C26C0A0DC80Q37297925-73B335E3-7890-4AAA-936D-02C1C8D89560Q37610880-3C1995B8-BD5E-47AA-8FFE-EEE9C6BD1549Q38051255-21E2863D-E0BF-4E13-88CF-F56B4EE4CD6AQ38057707-22045922-4694-44D0-94A9-21293D92A726Q38132249-44C2CF1F-B2A7-44E9-BF9C-84251EC66149Q38261287-3FBF844C-F5B3-499C-A639-B56635ECACF7Q38642426-DA031092-091A-4430-BA1C-41BC8ACE1A5AQ38664989-011D9761-BC3A-4A76-B5F5-1CE7105126A2Q38811356-A23E863F-E9A3-457B-97B2-141A8DBE099EQ39237924-B89E1A10-518D-46AE-BCDD-FACAB72A53BCQ39492601-4ABEBEA9-E655-4082-9015-710A06AD5015Q41159764-C5CC9347-05F6-4CEC-862C-7582BA4FC4D0Q42594342-A6ABDD57-AAF7-4844-A4CD-0525C81B1914Q42875828-2671BF70-30B4-4EB0-AA90-8328859DEFC1Q43089426-5AF00704-8862-40E5-8D72-79D586E8EA03Q47652510-BD475F23-2723-44F5-82F7-3FF5EAD1A1CAQ47687705-4614546F-1250-43B4-8AA0-70B0750334B1Q50082439-4D310E64-B7E0-4F18-B50B-F5014762646DQ52937788-E04B9057-EB46-435D-A35F-04AD44840B6DQ58799495-FF5A4C3B-5B1F-4912-AAD0-717D540BD969
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Predisposition for disrepair in the aged lung.
@en
Predisposition for disrepair in the aged lung.
@nl
type
label
Predisposition for disrepair in the aged lung.
@en
Predisposition for disrepair in the aged lung.
@nl
prefLabel
Predisposition for disrepair in the aged lung.
@en
Predisposition for disrepair in the aged lung.
@nl
P2093
P2860
P1476
Predisposition for disrepair in the aged lung.
@en
P2093
David C Neujahr
David Guidot
Jeffrey D Ritzenthaler
Jesse Roman
Mauricio Rojas
S Todd Mills
Susanne Roser-Page
Viranuj Sueblinvong
P2860
P356
10.1097/MAJ.0B013E318234C132
P407
P577
2012-07-01T00:00:00Z